Graves Disease With Thyroid-Stimulating Hormone Receptor-Blocking Autoantibodies During Pregnancy

Brigitte Decallonne; Pieter-Jan Martens; Annick Van den Bruel; Christine Vanhole; George J Kahaly

doi:10.7326/L19-0818

Graves Disease With Thyroid-Stimulating Hormone Receptor-Blocking Autoantibodies During Pregnancy

Ann Intern Med. 2020 Jun 2;172(11):767-769. doi: 10.7326/L19-0818. Epub 2020 Mar 24.

Authors

Brigitte Decallonne¹, Pieter-Jan Martens¹, Annick Van den Bruel², Christine Vanhole¹, George J Kahaly³

Affiliations

¹ University Hospitals Leuven, Leuven, Belgium (B.D., P.M., C.V.).
² Hospital St Jan, Bruges, Belgium (A.V.).
³ Johannes Gutenberg University Medical Center, Mainz, Germany (G.J.K.).

PMID: 32203974
DOI: 10.7326/L19-0818

No abstract available

Keywords: Antibodies; Autoimmune diseases; Drug therapy; Hyperthyroidism; Hypothyroidism; Placenta; Research laboratories; Therapeutic drug monitoring; Thyroid; Thyroid-stimulating hormone.

Publication types

Case Reports
Letter

MeSH terms

Adult
Autoantibodies / immunology*
Female
Graves Disease / complications*
Graves Disease / diagnosis
Graves Disease / immunology
Graves Disease / therapy
Humans
Pregnancy
Pregnancy Complications / diagnosis*
Pregnancy Complications / immunology
Pregnancy Complications / therapy
Receptors, Thyrotropin / immunology*

Substances

Autoantibodies
Receptors, Thyrotropin